Education May Overcome Reticence to Join Trials: Cancer advances threatened by resistance to research participation

    loading  Checking for direct PDF access through Ovid

Abstract

People in general, and cancer research subjects in particular, are reluctant to participate in clinical trials -- a trend that could undermine progress toward treatment, according to a new survey.

Related Topics

    loading  Loading Related Articles